2-159325866-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_013450.4(BAZ2B):āc.5996C>Gā(p.Thr1999Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,595,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_013450.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAZ2B | NM_013450.4 | c.5996C>G | p.Thr1999Ser | missense_variant | 35/37 | ENST00000392783.7 | NP_038478.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAZ2B | ENST00000392783.7 | c.5996C>G | p.Thr1999Ser | missense_variant | 35/37 | 5 | NM_013450.4 | ENSP00000376534.2 | ||
BAZ2B | ENST00000392782.5 | c.5888C>G | p.Thr1963Ser | missense_variant | 34/36 | 1 | ENSP00000376533.1 | |||
BAZ2B | ENST00000474437.1 | n.536C>G | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
BAZ2B | ENST00000548440.1 | n.510C>G | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 151564Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000904 AC: 21AN: 232280Hom.: 0 AF XY: 0.0000556 AC XY: 7AN XY: 125964
GnomAD4 exome AF: 0.0000485 AC: 70AN: 1444268Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 29AN XY: 717754
GnomAD4 genome AF: 0.000132 AC: 20AN: 151680Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74110
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at